The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntercede Regulatory News (IGP)

Share Price Information for Intercede (IGP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.854%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 105.50
IGP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

25 Apr 2018 07:00

RNS Number : 0021M
Intercede Group PLC
25 April 2018
 

 

 

 

25 April 2018

 

INTERCEDE GROUP plc

('Intercede', the 'Company' or the 'Group')

 

Director/PDMR Shareholding

 

 

Intercede, the software and service company specialising in identity, credential management and secure mobility, was notified on 24 April 2018 that on the same day, Chuck Pol, Non-Executive Chairman of the Company, purchased 62,500 ordinary shares of 1 pence each in the Company ("Shares"), at a price of 29.0 pence per share (the "Purchase").

 

Following the Purchase, Mr. Pol's total beneficial interest in the Company is 133,037 Shares representing approximately 0.26% of the Company's issued share capital.

 

 

ENQUIRIES

 

Intercede Group plc Tel. +44 (0)1455 558 111

Andrew Walker, Finance Director

 

finnCap Tel. +44 (0)20 7220 0500

Stuart Andrews, Corporate Finance

Simon Hicks, Corporate Finance

 

 

About Intercede

 

Intercede is a cybersecurity company specialising in digital identities, derived credentials and access control, enabling digital trust in a mobile world.

 

Headquartered in the UK, with offices in the US, we believe in a connected world in which people and technology are free to exchange information securely, and complex insecure passwords become a thing of the past.

 

Our vision is to make the highest levels of cybersecurity available to organizations and consumers alike, solving complexity and scalability issues by managing high volumes of digital credentials.

 

We have been delivering trusted solutions to high profile customers for over 20 years. Our team of experts has deployed millions of identities to governments, most of the largest aerospace and defence corporations, and major financial services and healthcare organizations, as well as leading telecommunications, cloud services and information technology firms, providing industry-leading employee and customer credential management systems.

 

For more information visit: www.intercede.com

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Chuck Pol - Non-Executive Chairman

2.

Reason for the Notification

a)

Position/status

See 1(a) above

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Intercede Group plc

b)

LEI

213800VFMNCYCDQ65C90

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 1 pence

Identification code

GB0003287249

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

29p

62,500

 

d)

Aggregated information:

· Aggregated volume

· Price

See 4(c) above

e)

Date of the transaction

24 April 2018

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHVZLFLVZFFBBV
Date   Source Headline
25th Sep 20131:00 pmRNSResult of AGM
25th Sep 20137:00 amRNSContract Wins and AGM Statement
9th Sep 20137:00 amRNSDirectors' Holding
29th Jul 20137:00 amRNSContract awards and Trading update
17th Jun 20137:00 amRNSDirector/PDMR Shareholding
4th Jun 20137:00 amRNSFinal Results
25th Apr 20137:00 amRNSContract Win
16th Apr 20137:00 amRNSAppointment of Non-Executive Director
5th Apr 20137:00 amRNSYear end trading update
1st Feb 20137:00 amRNSTrading Update
3rd Dec 20127:00 amRNSHolding(s) in Company
22nd Nov 20127:00 amRNSInterim Results
4th Oct 20127:00 amRNSTrading Update
26th Sep 20124:39 pmRNSResult of AGM
21st Aug 20127:00 amRNSAmendments to LTIP
4th Jul 20123:35 pmRNSDirector/PDMR Shareholding
14th Jun 20122:37 pmRNSIssue of Equity
12th Jun 201210:13 amRNSDirector/PDMR Shareholding and Issue of equity
5th Apr 20127:00 amRNSYear End Trading Update
15th Mar 20121:02 pmRNSIssue of Equity
17th Feb 20127:00 amRNSDirector/PDMR Shareholding
16th Feb 20127:00 amRNSTrading Update
12th Dec 20117:00 amRNSUS Expansion
7th Dec 201112:00 pmRNSSales Alliance
1st Dec 20117:00 amRNSInterim Results
14th Nov 20117:00 amRNSNew Partnership
4th Oct 20117:00 amRNSNew Contract Win
21st Sep 20112:55 pmRNSResult of AGM
21st Sep 20117:00 amRNSAGM Statement and Update
17th Aug 20117:00 amRNSDirector/PDMR Share Option Awards
4th Aug 20113:39 pmRNSDirector/PDMR Shareholding
7th Jun 20117:00 amRNSFinal Results
7th Apr 20117:00 amRNSTrading Update
18th Jan 20119:32 amRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSTransaction in Own Shares
30th Nov 201011:02 amRNSAdditional Listing and Director dealing
29th Nov 20107:00 amRNSIntercede Group Interim Results
4th Nov 20107:00 amRNSReduction of Share Capital
7th Oct 20107:54 amRNSPositive Trading Update
30th Sep 20107:00 amRNSNew Contract Win
24th Sep 20102:00 pmRNSResult of AGM
22nd Sep 20107:00 amRNSNew Contract Win
7th Sep 20107:00 amRNSPositive Trading Update
15th Jul 20107:00 amRNSLaunch of latest version of MyID PIV
6th Jul 20103:48 pmRNSChange of name of adviser
10th Jun 20107:00 amRNSFinal Results
8th Apr 20107:00 amRNSTrading Update
25th Mar 201012:30 pmRNSSettlement of Patent Dispute
2nd Mar 20107:00 amRNSDirector/PDMR Shareholding
1st Mar 20102:00 pmRNSMajor Subcontract with Thales

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.